Caprock Group LLC bought a new position in shares of CME Group Inc. (NASDAQ: CME) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commissi
Atria Investments Inc grew its position in shares of CME Group Inc. (NASDAQ: CME) by 10.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
CHICAGO, Feb. 13, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced its event contracts reached a new milestone of 100 million contracts traded since launch

CME Group Inc. Names Slate of Director Nominees

09:00am, Thursday, 12'th Feb 2026
CHICAGO, Feb. 12, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today announced its slate of candidates for its board of directors for election at the company's ann
CHICAGO, Feb. 12, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared its annual variable dividend and first-quarter regular dividend, both of which are pa
CME Group Inc. (NASDAQ: CME - Get Free Report) Director Dennis Suskind sold 748 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of
CHICAGO and SINGAPORE, Feb. 12, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch four South Asia edible oil futures contracts on March 2, 20
PASADENA, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Wedbush Securities , a diversified financial services firm, today announced its continued support for CME Group's prediction markets, which delivere

CME Group to Launch Single Stock Futures

12:37pm, Tuesday, 10'th Feb 2026
New financially settled futures contracts to include 50+ top U.S. single stocks including Alphabet, Meta, NVIDIA and Tesla CHICAGO, Feb. 10, 2026 /PRNewswire/ -- CME Group, the world's leading derivat
Stock News Novo sues Hims over compounded weight-loss drugs: Novo Nordisk (NVO) filed suit to stop Hims and Hers Health (HIMS) from selling compounded semaglutide
CME Group Inc. (NASDAQ: CME - Get Free Report) shares hit a new 52-week high during trading on Tuesday after The Goldman Sachs Group raised their price target on the stock from $264.00 to $266.00. The
Twin Capital Management Inc. cut its holdings in shares of CME Group Inc. (NASDAQ: CME) by 87.4% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned
NEW YORK--(BUSINESS WIRE)--FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group's EBS Market central lim
Wilson Asset Management International PTY Ltd. lessened its stake in CME Group Inc. (NASDAQ: CME) by 10.2% in the third quarter, according to the company in its most recent 13F filing with the Securit
CME Group remains a Hold; shares reflect robust fundamentals but limited near-term upside at 25x forward earnings. CME posted record annual revenue and earnings, with Q4 operating margins near 67% and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE